The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,963,589 in first-year total cost, median $554,698.
Most frequent study sections
- Special Emphasis Panel[ZAI1 HSC-I (S1)]13
Most frequent institutions
- DUKE UNIVERSITY2
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- BRIGHAM AND WOMEN'S HOSPITAL1
- CHROMOLOGIC, LLC1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Anti-ceramide Ab Preserves Intestinal Stem Cells and Prevents GI-ARS and GI-DEARE1U01AI187049-01 | KOLESNICK, RICHARD N | SLOAN-KETTERING INST CAN RESEARCH, NY | $597,518 | ZAI1 |
| 2025 | Development of MIIST305 as a Mitigator for Gastrointestinal Acute Radiation Syndrome and Identification of Biomarkers of Radiation Injury and Drug Efficacy1U01AI187042-01 | BROUSTAS, CONSTANTINOS G.TURNER, HELEN C | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $595,009 | ZAI1 |
| 2025 | Thrombopoietin mimetic (TPOm) as a medical countermeasure for GI-ARS1U01AI187051-01 | GHOSH, SANCHITA PGUHA, CHANDANYANG, WENG-LANG | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $593,823 | ZAI1 |
| 2025 | Harnessing Trained Immunity as a Radiation Medical Countermeasure1U01AI186972-01 | LEDERER, JAMES A. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $586,619 | ZAI1 |
| 2025 | Ghrelin as Radiation Countermeasure: Mechanism of Its Action1U01AI186997-01 | BRENNER, MAXVARGHESE, ASHAWANG, PING | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $586,240 | ZAI1 |
| 2025 | A Novel RAD51-BRCA2 Complex Stabilizing Drug: A Medical Countermeasure for Mitigating Accidental Radiation Exposure1U01AI187043-01 | AHMED, MAHMOUD SALAMAAROUMOUGAME, ASAITHAMBYSADEK, HESHAM | UNIVERSITY OF ARIZONA, AZ | $583,468 | ZAI1 |
| 2025 | Development of angiogenin as a novel radiation medical countermeasure for acute radiation syndrome1U01AI187053-01 | SINGH, VIJAY K | HENRY M. JACKSON FDN FOR THE ADV MIL/MED, MD | $554,698 | ZAI1 |
| 2025 | Development of YK-4-250, a radiation mitigator of GI-ARS1U01AI187033-01 | BROWN, MILTON L.KUMAR, VIDYA P. | OLD DOMINION UNIVERSITY, VA | $552,787 | ZAI1 |
| 2025 | Mitigation of hematopoietic acute radiation syndrome (ARS) by inhibition of tyrosine kinase Fgr1U01AI186994-01 | BINDER, ROBERT JGREENBERGER, JOEL SMUKHERJEE, AMITAVA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $547,537 | ZAI1 |
| 2025 | Mitigation of multi-organ delayed effects of acute radiation exposure (DEARE) with ACE2 agonist diminazene aceturate.1U01AI186939-01 | HIMBURG, HEATHER A | MEDICAL COLLEGE OF WISCONSIN, WI | $546,000 | ZAI1 |
| 2025 | Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration1U01AI186969-01 | KIRSCH, DAVID GUYLEE, CHANG-LUNGROPER, JATIN | DUKE UNIVERSITY, NC | $515,326 | ZAI1 |
| 2025 | Investigation of the mechanisms of H-ARS mitigation by the orally administrated GI-ARS mitigator LR-IFN-beta1U01AI187044-01 | GREENBERGER, JOEL SROGERS, CLAUDE J. | CHROMOLOGIC, LLC, CA | $470,309 | ZAI1 |
| 2025 | Thioredoxin derivatives for radiation mitigation1U01AI187020-01 | KANG, YUBIN | DUKE UNIVERSITY, NC | $234,255 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.